Reclassification of genetic variants in children with long QT syndrome.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
09 2020
Historique:
received: 28 10 2019
revised: 16 04 2020
accepted: 17 04 2020
pubmed: 10 5 2020
medline: 21 5 2021
entrez: 9 5 2020
Statut: ppublish

Résumé

Genes encoding cardiac ion channels or regulating proteins have been associated with the inherited form of long QT syndrome (LQTS). Complex pathophysiology and missing functional studies, however, often bedevil variant interpretation and classification. We aimed to evaluate the rate of change in variant classification based on current interpretation standards and dependent on clinical findings. Medical charts of children with a molecular genetic diagnosis of LQTS presenting at our centers were retrospectively reviewed. Reinterpretation of originally reported variants in genes associated with LQTS was performed based on current knowledge (March 2019) and according to the "Standards and Guidelines for the Interpretation of Sequence Variants" by the ACMG 2015. About 84 distinct (likely) pathogenic variants identified in 127 patients were reinterpreted. In 12 variants (12/84, 14.3%), classification changed from (likely) pathogenic to variant of unknown significance (VUS). One of these variants was a hypomorphic allele escaping the standard variant classification. Individuals with variants that downgraded to VUS after reevaluation showed significantly lower Schwartz scores and QTc intervals compared to individuals with unchanged variant characterization. This finding confirms genetic variant interpretation as a dynamic process and underlines the importance of ongoing genetic counseling, especially in LQTS patients with minor clinical criteria.

Sections du résumé

BACKGROUND
Genes encoding cardiac ion channels or regulating proteins have been associated with the inherited form of long QT syndrome (LQTS). Complex pathophysiology and missing functional studies, however, often bedevil variant interpretation and classification. We aimed to evaluate the rate of change in variant classification based on current interpretation standards and dependent on clinical findings.
METHODS
Medical charts of children with a molecular genetic diagnosis of LQTS presenting at our centers were retrospectively reviewed. Reinterpretation of originally reported variants in genes associated with LQTS was performed based on current knowledge (March 2019) and according to the "Standards and Guidelines for the Interpretation of Sequence Variants" by the ACMG 2015.
RESULTS
About 84 distinct (likely) pathogenic variants identified in 127 patients were reinterpreted. In 12 variants (12/84, 14.3%), classification changed from (likely) pathogenic to variant of unknown significance (VUS). One of these variants was a hypomorphic allele escaping the standard variant classification. Individuals with variants that downgraded to VUS after reevaluation showed significantly lower Schwartz scores and QTc intervals compared to individuals with unchanged variant characterization.
CONCLUSION
This finding confirms genetic variant interpretation as a dynamic process and underlines the importance of ongoing genetic counseling, especially in LQTS patients with minor clinical criteria.

Identifiants

pubmed: 32383558
doi: 10.1002/mgg3.1300
pmc: PMC7506994
doi:

Substances chimiques

CALM2 protein, human 0
Calmodulin 0
ERG1 Potassium Channel 0
KCNH2 protein, human 0
KCNJ2 protein, human 0
KCNQ1 Potassium Channel 0
KCNQ1 protein, human 0
NAV1.5 Voltage-Gated Sodium Channel 0
Potassium Channels, Inwardly Rectifying 0
SCN5A protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1300

Informations de copyright

© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Références

Heart Rhythm. 2013 Dec;10(12):1932-63
pubmed: 24011539
Dis Model Mech. 2012 Mar;5(2):220-30
pubmed: 22052944
Hum Mutat. 2018 Nov;39(11):1517-1524
pubmed: 30192042
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):868-77
pubmed: 22895603
Circulation. 2009 Nov 3;120(18):1761-7
pubmed: 19841298
Heart Rhythm. 2018 Apr;15(4):555-561
pubmed: 29197658
Heart Rhythm. 2017 Aug;14(8):e155-e217
pubmed: 28286247
Curr Probl Cardiol. 2013 Oct;38(10):417-55
pubmed: 24093767
Physiol Rev. 2017 Jan;97(1):89-134
pubmed: 27807201
Ann Med. 2006;38(4):294-304
pubmed: 16754261
J Cardiovasc Transl Res. 2015 Apr;8(3):187-97
pubmed: 25854863
Europace. 2015 Oct;17 Suppl 2:ii1-6
pubmed: 26842110
Mol Genet Genomic Med. 2020 Sep;8(9):e1300
pubmed: 32383558
J Am Coll Cardiol. 2011 Jan 4;57(1):51-9
pubmed: 21185501
Ann Med. 2009;41(3):234-40
pubmed: 19160088
Circulation. 2011 Nov 15;124(20):2181-4
pubmed: 22083145
Circ Res. 2013 Mar 1;112(5):826-30
pubmed: 23303164
Circulation. 2009 Nov 3;120(18):1752-60
pubmed: 19841300
Nat Commun. 2014 Nov 24;5:5535
pubmed: 25417810
Circulation. 2020 Feb 11;141(6):418-428
pubmed: 31983240
Heart Rhythm. 2020 Feb;17(2):315-323
pubmed: 31493592
Circulation. 2018 Feb 6;137(6):619-630
pubmed: 29431662
Nature. 2011 Jul 10;475(7356):353-8
pubmed: 21743477
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
N Engl J Med. 2003 May 8;348(19):1866-74
pubmed: 12736279

Auteurs

Dominik S Westphal (DS)

Institute of Human Genetics, Technical University of Munich, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.

Tobias Burkard (T)

Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany.

Alexander Moscu-Gregor (A)

Center for Human Genetics and Laboratory Diagnostics, Martinsried, Germany.

Roman Gebauer (R)

Department of Pediatric Cardiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.

Gabriele Hessling (G)

Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany.

Cordula M Wolf (CM)

Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH